'Aged fat'—combo of age, obesity—may damage blood vessels, hasten heart failure

Researchers have identified an enzyme that may explain why age and obesity can combine to restrict blood flow through blood vessels and increase risks of heart failure.

Researchers at the Medical College of Georgia at Augusta University, publishing findings online July 10 in Arteriosclerosis, Thrombosis and Vascular Biology, discovered problems with the enzyme ADAM17 in obese and older patients.

"Older obese patients and sometimes women who suffer heart failure go to the cardiac catheterization lab, and the cardiologist finds nothing that would explain their heart failure," said Zsolt Bagi, MD, PhD, vascular biologist at the Medical College of Georgia at Augusta University. "They have normal large blood vessels in the heart [but] still the heart failure has developed."

The researchers dubbed the risk “aged fat” with evidence the two factors can have an additive effect. The walls of the coronary microvasculature can thicken without any atherosclerotic plaque, which is commonly linked to heart disease.

ADAM17 levels increase with obesity, while production of a natural inhibitor decreases with age. This exposure leads the walls of the microvasculature to become thicker, less elastic and unable to dilate properly.

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.